reported that high-expression MIF genotypes (e.g., CATT7 and -173C) are associated with exacerbated acute graft-versus-host disease (GVHD) and glucocorticoid resistance in HSCT patients, likely due to sustained pro-inflammatory signaling and impaired immune regulation (41). This evidence concerns the gene MIF and graft versus host disease.